Large-scale testing (Phase 3)UnknownNCT04084626What this trial is testingPD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBVWho this might be right forEBV Infection Beijing Friendship Hospital 40
Not applicableLooking for participantsNCT00032513What this trial is testingGenetic Studies of Chronic Active Epstein-Barr DiseaseWho this might be right forChronic Active Epstein-Barr Virus National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)UnknownNCT05384743What this trial is testingRituximab Monotherapy for EBV-HLH and CAEBVWho this might be right forSecondary Hemophagocytic LymphohistiocytosisChronic Active Epstein-Barr Virus Infection Beijing Friendship Hospital 30
Not applicableUnknownNCT05532826What this trial is testingClinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCTWho this might be right forChronic Active Epstein-Barr Virus InfectionVirus-Associated Hemophagocytic Syndrome Beijing Friendship Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT07381738What this trial is testingUnrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative DisordersWho this might be right forEpstein-Barr Virus-associated Lymphoproliferative DiseasesChronic Active Epstein-Barr Virus InfectionEBV Associated Lymphoma+1 more Fudan University 80
Not applicableLooking for participantsNCT05978141What this trial is testingA Registry for People With T-cell LymphomaWho this might be right forT-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+28 more Memorial Sloan Kettering Cancer Center 1,000
Early research (Phase 1)Active Not RecruitingNCT00710892What this trial is testingCASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide GeneWho this might be right forAcute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaMyelodysplastic Syndrome+1 more Baylor College of Medicine 10
Early research (Phase 1)Study completedNCT02669017What this trial is testingStudy of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)Who this might be right forNon-Hodgkin LymphomaBurkitt's LymphomaChronic Lymphocytic Leukemia+6 more ADC Therapeutics S.A. 183
Testing effectiveness (Phase 2)Study completedNCT01998633What this trial is testingReduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)Who this might be right forHemophagocytic LymphohistiocytosisChronic Active Epstein-Barr Virus InfectionChronic Granulomatous Disease+3 more Medical College of Wisconsin 47
Early research (Phase 1)Study completedNCT01447056What this trial is testingMost Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated DiseasesWho this might be right forHodgkin LymphomaNon-Hodgkin LymphomaLymphoproliferative Disorder+3 more Baylor College of Medicine 37
Not applicableActive Not RecruitingNCT05236764What this trial is testingHaploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 DepletionWho this might be right forAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more Baylor College of Medicine 3
Early research (Phase 1)Looking for participantsNCT03666000What this trial is testingDose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)Who this might be right forNon-Hodgkin LymphomaB-cell Acute Lymphoblastic LeukemiaChronic Lymphocytic Leukemia+1 more Imugene Limited 135
Early research (Phase 1)Active Not RecruitingNCT02287311What this trial is testingMost Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)Who this might be right forHodgkin DiseaseNon-Hodgkin LymphomaSevere Chronic Active Epstein Barr Virus+3 more Baylor College of Medicine 38
Not applicableUnknownNCT05841342What this trial is testingProspective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH PatientsWho this might be right forSecondary Hemophagocytic LymphohistiocytosisChronic Active Epstein-Barr Virus Infection Beijing Friendship Hospital 128
Early research (Phase 1)Ended earlyNCT00383097What this trial is testingLmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's LymphomaWho this might be right forHodgkins LymphomaNon-Hodgkin Lymphoma Baylor College of Medicine 6
Early research (Phase 1)Study completedNCT04450069What this trial is testingCLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell MalignanciesWho this might be right forRelapsed/Refractory B-cell LymphomasDiffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+9 more Calibr, a division of Scripps Research 18
Not applicableNot Yet RecruitingNCT06491719What this trial is testingA Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCTWho this might be right forCAEBV (Chronic Active Epstein-Barr Virus Infection) SyndromeEBVHemophagocytic Lymphohistiocytoses Beijing Friendship Hospital 15
Post-approval studies (Phase 4)UnknownNCT05039580What this trial is testingProgrammed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line TherapyWho this might be right forEBV Infection The First Affiliated Hospital of Soochow University 36
Early research (Phase 1)Study completedNCT01956084What this trial is testingCytotoxic T Cells to Treat Relapsed EBV-positive LymphomaWho this might be right forHodgkin DiseaseNon Hodgkin LymphomaLymphoepithelioma+2 more Catherine Bollard 10
Testing effectiveness (Phase 2)Study completedNCT00110045What this trial is testingCaspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell TransplantWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 171